Anti-malarial and haematological evaluation of the ethanolic, ethyl acetate and aqueous fractions of Chromolaena odorata

Abstract Malaria is a global health challenge with endemicity in sub-Saharan Africa, where there are multiple drug-resistant strains and limited access to modern health care facilities, especially in rural areas. Studies indicate that African traditional medicine could make a substantial contributio...

Full description

Bibliographic Details
Main Authors: Tobiloba Christiana Elebiyo, Olarewaju Michael Oluba, Oluyomi Stephen Adeyemi
Format: Article
Language:English
Published: BMC 2023-11-01
Series:BMC Complementary Medicine and Therapies
Subjects:
Online Access:https://doi.org/10.1186/s12906-023-04200-8
_version_ 1797630427674968064
author Tobiloba Christiana Elebiyo
Olarewaju Michael Oluba
Oluyomi Stephen Adeyemi
author_facet Tobiloba Christiana Elebiyo
Olarewaju Michael Oluba
Oluyomi Stephen Adeyemi
author_sort Tobiloba Christiana Elebiyo
collection DOAJ
description Abstract Malaria is a global health challenge with endemicity in sub-Saharan Africa, where there are multiple drug-resistant strains and limited access to modern health care facilities, especially in rural areas. Studies indicate that African traditional medicine could make a substantial contribution to the reduction of malaria-related deaths and achievement of universal health coverage (UHC), particularly in these regions. Thus, this study evaluated the curative antimalarial effects of Chromolaena odorata leaf extract using mouse model. Forty-five (45) albino mice weighing between 18 and 22 g were grouped into nine groups of 5 animals each. Animals in groups 2–9 were infected with the chloroquine-resistant strain of Plasmodium berghei, while animals in groups 3–9 were subsequently treated with 10 mg/kg chloroquine, a combination of 1.4 mg/kg artemether and 8.75 mg/kg lumefantrine (Coartem), and varying concentrations of the fraction from the aqueous leaf extract of C. odorata at day 3 post-infection. The findings from this study indicate that treatment with 400 mg/kg of the ethanolic fraction of the crude extract resulted in a significant decrease in parasite load (97.6%), which was comparable to the activities of the conventional drugs chloroquine (98.6%) and Coartem (98.8%). The ethyl acetate and ethanolic fractions at 400 mg/kg also ameliorated the significant alterations in the red blood cells, white blood cells, and platelets of the infected animals. The high antimalarial activity displayed by the ethanolic fraction could be due to the presence of quercetin and kaempferol, as detected by high performance liquid chromatography (HPLC) analysis. The findings suggest that the fractions from C. odorata could serve as an alternative source of malaria therapy, particularly in sub-Saharan Africa.
first_indexed 2024-03-11T11:07:12Z
format Article
id doaj.art-192795d5976b47f1b7bf4ad454061248
institution Directory Open Access Journal
issn 2662-7671
language English
last_indexed 2024-03-11T11:07:12Z
publishDate 2023-11-01
publisher BMC
record_format Article
series BMC Complementary Medicine and Therapies
spelling doaj.art-192795d5976b47f1b7bf4ad4540612482023-11-12T12:06:40ZengBMCBMC Complementary Medicine and Therapies2662-76712023-11-0123111510.1186/s12906-023-04200-8Anti-malarial and haematological evaluation of the ethanolic, ethyl acetate and aqueous fractions of Chromolaena odorataTobiloba Christiana Elebiyo0Olarewaju Michael Oluba1Oluyomi Stephen Adeyemi2SDG 03 Group – Good Health & Well-being, Landmark UniversityDepartment of Biochemistry, Landmark UniversitySDG 03 Group – Good Health & Well-being, Landmark UniversityAbstract Malaria is a global health challenge with endemicity in sub-Saharan Africa, where there are multiple drug-resistant strains and limited access to modern health care facilities, especially in rural areas. Studies indicate that African traditional medicine could make a substantial contribution to the reduction of malaria-related deaths and achievement of universal health coverage (UHC), particularly in these regions. Thus, this study evaluated the curative antimalarial effects of Chromolaena odorata leaf extract using mouse model. Forty-five (45) albino mice weighing between 18 and 22 g were grouped into nine groups of 5 animals each. Animals in groups 2–9 were infected with the chloroquine-resistant strain of Plasmodium berghei, while animals in groups 3–9 were subsequently treated with 10 mg/kg chloroquine, a combination of 1.4 mg/kg artemether and 8.75 mg/kg lumefantrine (Coartem), and varying concentrations of the fraction from the aqueous leaf extract of C. odorata at day 3 post-infection. The findings from this study indicate that treatment with 400 mg/kg of the ethanolic fraction of the crude extract resulted in a significant decrease in parasite load (97.6%), which was comparable to the activities of the conventional drugs chloroquine (98.6%) and Coartem (98.8%). The ethyl acetate and ethanolic fractions at 400 mg/kg also ameliorated the significant alterations in the red blood cells, white blood cells, and platelets of the infected animals. The high antimalarial activity displayed by the ethanolic fraction could be due to the presence of quercetin and kaempferol, as detected by high performance liquid chromatography (HPLC) analysis. The findings suggest that the fractions from C. odorata could serve as an alternative source of malaria therapy, particularly in sub-Saharan Africa.https://doi.org/10.1186/s12906-023-04200-8Botanical drugHaematologyMalaria treatmentMedicinal biochemistryPlasmodium berghei
spellingShingle Tobiloba Christiana Elebiyo
Olarewaju Michael Oluba
Oluyomi Stephen Adeyemi
Anti-malarial and haematological evaluation of the ethanolic, ethyl acetate and aqueous fractions of Chromolaena odorata
BMC Complementary Medicine and Therapies
Botanical drug
Haematology
Malaria treatment
Medicinal biochemistry
Plasmodium berghei
title Anti-malarial and haematological evaluation of the ethanolic, ethyl acetate and aqueous fractions of Chromolaena odorata
title_full Anti-malarial and haematological evaluation of the ethanolic, ethyl acetate and aqueous fractions of Chromolaena odorata
title_fullStr Anti-malarial and haematological evaluation of the ethanolic, ethyl acetate and aqueous fractions of Chromolaena odorata
title_full_unstemmed Anti-malarial and haematological evaluation of the ethanolic, ethyl acetate and aqueous fractions of Chromolaena odorata
title_short Anti-malarial and haematological evaluation of the ethanolic, ethyl acetate and aqueous fractions of Chromolaena odorata
title_sort anti malarial and haematological evaluation of the ethanolic ethyl acetate and aqueous fractions of chromolaena odorata
topic Botanical drug
Haematology
Malaria treatment
Medicinal biochemistry
Plasmodium berghei
url https://doi.org/10.1186/s12906-023-04200-8
work_keys_str_mv AT tobilobachristianaelebiyo antimalarialandhaematologicalevaluationoftheethanolicethylacetateandaqueousfractionsofchromolaenaodorata
AT olarewajumichaeloluba antimalarialandhaematologicalevaluationoftheethanolicethylacetateandaqueousfractionsofchromolaenaodorata
AT oluyomistephenadeyemi antimalarialandhaematologicalevaluationoftheethanolicethylacetateandaqueousfractionsofchromolaenaodorata